1995
DOI: 10.1016/0960-0760(95)00116-h
|View full text |Cite
|
Sign up to set email alerts
|

Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
21
0
1

Year Published

1997
1997
2007
2007

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 75 publications
(25 citation statements)
references
References 26 publications
3
21
0
1
Order By: Relevance
“…Progestins have been shown to inhibit the reductive 17␤-HSD activity as well as to stimulate the oxidative 17␤-HSD activity, respectively in BC cell lines. In contrast, sulfotransferase activity was shown to be increased in MCF-7 and T-47D cell lines when progestins were added [32,41,60,61]. A recent study in BC cells demonstrated different effects on various enzymes depending on what type of progestin and estradiol was combined with [44].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Progestins have been shown to inhibit the reductive 17␤-HSD activity as well as to stimulate the oxidative 17␤-HSD activity, respectively in BC cell lines. In contrast, sulfotransferase activity was shown to be increased in MCF-7 and T-47D cell lines when progestins were added [32,41,60,61]. A recent study in BC cells demonstrated different effects on various enzymes depending on what type of progestin and estradiol was combined with [44].…”
Section: Discussionmentioning
confidence: 99%
“…Breast tissue and mammary cancer cells have been shown to possess the enzymatic systems necessary for the intratumoral biosynthesis of estrogens from precursor molecules circulating in plasma. Three main enzymes are important in this process: aromatase, which converts androgens to estrogens [18][19][20], E 1 S-sulfatase (STS) which hydrolizes E 1 S to E 1 [20][21][22][23][24][25][26][27][28], and 17␤-hydroxysteroid dehydrogenase type 1 (17␤HSD-1) which reduces E 1 to E 2 [29][30][31][32]. The activity of STS in breast tumors has been shown to be 10-500-fold higher than aromatase activity [33][34][35].…”
Section: Introductionmentioning
confidence: 99%
“…8) as potential STS inhibitors, most of them marketed drugs for estrogen-related disorders or as oral contraceptives (reviewed in Refs. 132,133). In many of these studies, intact breast tumor cells were incubated with labeled E1S and the formation of E1 and E2 was measured in the presence of progestins; this experimental setting leaves it open whether a compound acts as direct STS inhibitor (by binding to the target protein), or whether compounds influence cellular levels of active STS (e.g., by acting on STS transcription or post-translational modification).…”
Section: Progestinsmentioning
confidence: 99%
“…While the local production in bone and adipocytes might serve physiological needs, malignant breast tumors also appear to produce their own estradiol locally (Sasano et al 1997, Chetrite et al 2000, Belanger et al 2002. Intratumoral estrogen levels have been shown to be several folds higher than corresponding systemic levels (Pasqualini et al 1995). Although malignant breast tissue contains all the enzymes necessary for the local biosynthesis of estrogens, there is increasing evidence that the cytochrome P450 enzyme aromatase is mainly responsible for the elevated local levels of biologically active estradiol.…”
Section: Introductionmentioning
confidence: 99%